SD

Shakuntla Devi

Active Director Director DIN 01149413
DIN 01149413 First appointment Feb 1999 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 1999
Shareholding value •••• Premium profile

About Shakuntla Devi

Data last updated:

Shakuntla Devi is a Director at Endocard India Private Limited (since 1999). The company operates in Pharma. Endocard India Private Limited reported revenue of ₹7.21 Cr (FY 2025).

DIN 01149413
Primary Designation Director
Industry Pharma
First Appointment 01 Feb 1999
Oldest Company Age 27 yrs
Largest company Endocard India Private Limited · ₹7.21 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Endocard India Private Limited U24239DL1999PTC098174
Director01 Feb 19991999₹7.21 Cr (FY 2025)Active

Board colleagues of Shakuntla Devi

NameDINCompanyDesignation
Rajiv Khurana00985759Endocard India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Endocard India Private Limited
Premium access

Shareholding and investment profile for Shakuntla Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shakuntla Devi

Shakuntla Devi currently holds 1 directorship: Endocard India Private Limited (Director, since 01 Feb 1999, revenue ₹7.21 Cr (FY 2025)).

Shakuntla Devi was first appointed on 01 Feb 1999 as Director at Endocard India Private Limited.

The current boards of Shakuntla Devi's companies include Rajiv Khurana (Endocard India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available